STAGE III PRIMARY PERITONEAL CANCER AJCC V7
Clinical trials for STAGE III PRIMARY PERITONEAL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PRIMARY PERITONEAL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PRIMARY PERITONEAL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ovarian cancer patients get immune boost in new drug trial
Disease control OngoingThis early-phase study tested whether adding the immunotherapy drug durvalumab to standard chemotherapy helps women with advanced ovarian, fallopian tube, or primary peritoneal cancer. 18 participants received the combination to see how it affects the immune system and tumor grow…
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Heated chemo during surgery shows promise for Tough-to-Treat ovarian cancer
Disease control OngoingThis early-phase study tests whether giving a dose of heated chemotherapy directly into the abdomen during surgery can help lower the risk of cancer returning in people with advanced ovarian, fallopian tube, uterine, or peritoneal cancer. About 40 participants with stage III or I…
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Ovarian cancer drug trial tests DNA changes before surgery
Knowledge-focused OngoingThis early-phase trial is testing how the drug adavosertib affects the DNA of tumor cells in 38 people with advanced ovarian, fallopian tube, or peritoneal cancer before they have surgery. The goal is to learn how the drug changes the cancer's DNA, which may help doctors plan bet…
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 12:10 UTC